
In Entwicklung
Business·gesternKI-Zusammenfassung
AstraZeneca shares plunge after reports of talks to acquire Bristol Myers Squibb
More than £17bn was wiped off AstraZeneca's market value after reports it is discussing a takeover of US rival Bristol Myers Squibb in a potential $400bn deal.
G
Guardian Business5 Min. Lesezeit
